Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Autor:	Thaçi, Diamant1 diamant.thaci@uksh.de, Simpson, Eric L.2, Beck, Lisa A.3, Bieber, Thomas4, Blauvelt, Andrew5, Papp, Kim6, Soong, Weily7, Worm, Margitta8, Szepietowski, Jacek C.9, Sofen, Howard10, Makoto Kawashima11, Wu, Richard12, Weinstein, Steven P.12, Graham, Neil M. H.12, Pirozzi, Gianluca13, Teper, Ariel13, Sutherland, E. Rand14, Mastey, Vera12, Stahl, Neil12, Yancopoulos, George D.12
Zdroj:	Lancet. 1/2/2016, Vol. 387 Issue 10013, p40-52. 13p. 1 Diagram, 3 Charts, 2 Graphs.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu